Healthcare [ 10/13 ] | Medical Instruments & Supplies [ 125/159 ]
NASDAQ | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 4, 24 | -0.16 Decreased by -433.33% | -0.13 Decreased by -23.08% |
| Jan 5, 24 | -0.05 Decreased by -600% | -0.07 Increased by +28.57% |
| Oct 4, 23 | -0.12 Decreased by -100% | -0.13 Increased by +7.69% |
| Jul 12, 23 | 0.02 Increased by +100% | 0.02 |
| Mar 30, 23 | -0.03 Decreased by -200% | -0.01 Decreased by -200% |
| Jan 5, 23 | 0.01 Increased by +150% | -0.01 Increased by +200% |
| Oct 6, 22 | -0.06 Decreased by -200% | -0.02 Decreased by -200% |
| Jul 12, 22 | 0.01 Increased by +101.98% | 0.01 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Feb 29, 24 | 75.18 M Decreased by -6.85% | -190.44 M Decreased by -1.91 K% | Decreased by -253.3% Decreased by -2.06 K% |
| Nov 30, 23 | 79.07 M Decreased by -7.44% | -29.05 M Decreased by -242.3% | Decreased by -36.74% Decreased by -269.82% |
| Aug 31, 23 | 78.68 M Decreased by -3.51% | 45.88 M Increased by +452.85% | Increased by +58.32% Increased by +465.66% |
| May 31, 23 | 91.07 M Increased by +4.69% | -21.47 M Decreased by -242.59% | Decreased by -23.57% Decreased by -227.26% |
| Feb 28, 23 | 80.71 M Increased by +9.11% | -9.48 M Decreased by -91.31% | Decreased by -11.75% Decreased by -75.33% |
| Nov 30, 22 | 85.43 M Increased by +9.13% | -8.49 M Decreased by -1.62% | Decreased by -9.93% Increased by +6.89% |
| Aug 31, 22 | 81.54 M Increased by +5.93% | -13 M Decreased by -86.52% | Decreased by -15.95% Decreased by -76.07% |
| May 31, 22 | 87 M Increased by +13.22% | -6.27 M Increased by +67.81% | Decreased by -7.2% Increased by +71.57% |
AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.